Is Halozyme Therapeutics, Inc. (HALO) a Buy, Sell, or Hold?
Halozyme Therapeutics, Inc.
NASDAQ:HALO
$75.8651 USD
$0.82 (1.09%)
- Volume
- 454.46K
- Average Volume
- 1.81M
- Market Capitalization
- $9B
- P/E Ratio
- 25.98
- Dividend Yield
- 0.00%
- Price Target
- $91.50
- Year High
- $82.26
- Year Low
- $55.64
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.76
HALO vs. The Competition
| Properties | HALO | ABVX | ATR | CAI |
|---|---|---|---|---|
| Market Cap | $9B | $9.95B | $8.31B | $4.87B |
| Shares Outstanding | $118.61M | $73.43M | $63.82M | $282.68M |
| P/E Ratio | 25.98 | -24.8 | 22.03 | -11.07 |
| EPS | 2.95 | -4.83 | 6.04 | 0.12 |
| Day Low | 73.8901 | 133.382 | 128.45 | 16.9 |
| Day high | 76.05 | 137.32 | 130.765 | 17.85 |
| Year Low | 55.64 | 9.25 | 103.23 | 14.19 |
| Year High | 82.26 | 148.83 | 164.28 | 42.5 |
| Average Price 50 | 70.8832 | 116.0752 | 119.576 | 17.1164 |
| Average Price 200 | 69.16145 | 114.0274 | 125.2138 | 22.61597 |
| Volume | 454.46K | 595.84K | 192.51K | 3.68M |
| Average Volume | - | - | - | - |